Aarhus University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Aarhus University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013104
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aarhus University (Aarhus) is a university that undertakes activities related to research, talent development, knowledge exchange and education. The university offers bachelor’s degree programmes, master’s degree programmes and PhD programmes in various disciplines. Its areas of academic interest comprise arts, science and technology, health and business and social sciences. Aarhus’s operates through various departments in the areas of aesthetics and communication, agroecology, dentistry, economics and business, forensic medicine, law, mathematics, molecular biology and genetics, among others. The university also provides public sector consultancy services and has research collaborations with private companies and educational institutions. Aarhus is headquartered in Aarhus, Denmark.

Aarhus University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aarhus University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aarhus University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aarhus University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aarhus University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aarhus University, Medical Devices Deals, 2011 to YTD 2017 9
Aarhus University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aarhus University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
RedHill Biopharma Enters into Research Agreement with Aarhus University 11
MipSalus Partners with Aarhus University 12
Meta-IQ Enters into Partnership with Aarhus University 13
Licensing Agreements 14
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 14
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 15
Aarhus University – Key Competitors 16
Aarhus University – Key Employees 17
Aarhus University – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Government and Public Interest 19
Aug 16, 2016: Molecule prevents effect of chemotherapy 19
Product News 20
Sep 20, 2017: Characterization of a Slowly Proliferating Population of Melanoma Cells with High Metastatic Properties 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Aarhus University, Pharmaceuticals & Healthcare, Key Facts 2
Aarhus University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aarhus University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aarhus University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aarhus University, Deals By Therapy Area, 2011 to YTD 2017 8
Aarhus University, Medical Devices Deals, 2011 to YTD 2017 9
Aarhus University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
RedHill Biopharma Enters into Research Agreement with Aarhus University 11
MipSalus Partners with Aarhus University 12
Meta-IQ Enters into Partnership with Aarhus University 13
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 14
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 15
Aarhus University, Key Competitors 16
Aarhus University, Key Employees 17
Aarhus University, Subsidiaries 18

★海外企業調査レポート[Aarhus University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • State Atomic Energy Corporation Rosatom:企業の戦略的SWOT分析
    State Atomic Energy Corporation Rosatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Bonterra Energy Corp (BNE):企業の財務・戦略的SWOT分析
    Bonterra Energy Corp (BNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Benihana Inc.:企業の戦略・SWOT・財務情報
    Benihana Inc. - Strategy, SWOT and Corporate Finance Report Summary Benihana Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Basware Oyj (BAS1V):企業の財務・戦略的SWOT分析
    Basware Oyj (BAS1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • D.H. Cyprotels Plc:企業の戦略・SWOT・財務情報
    D.H. Cyprotels Plc - Strategy, SWOT and Corporate Finance Report Summary D.H. Cyprotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Securitas AB (SECU B):企業の財務・戦略的SWOT分析
    Securitas AB (SECU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Renata Ltd (RENATA):企業の財務・戦略的SWOT分析
    Summary Renata Ltd (Renata), formerly Pfizer Ltd, is a pharmaceutical and animal health product company. The company manufactures generic pharmaceutical products including hormones, contraceptives, anti cancer drugs, oral preparations, and other drugs. Its pharmaceutical product portfolio comprises …
  • Innergex Renewable Energy Inc:発電所・企業SWOT分析
    Innergex Renewable Energy Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Vysarn Ltd (MHM):企業の戦略的SWOT分析
    Vysarn Ltd (MHM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Tanita Corp:企業の戦略的SWOT分析
    Tanita Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Bachem Holding AG (BANB):製薬・医療:M&Aディール及び事業提携情報
    Summary Bachem Holding AG (Bachem) is a technology-based biochemical company which develops and manufactures peptides and complex organic molecules including active pharmaceutical ingredients and biochemicals for research purposes. Bachem offers its products and services to the pharmaceutical and bi …
  • Woolworths Limited:戦略・SWOT・企業財務分析
    Woolworths Limited - Strategy, SWOT and Corporate Finance Report Summary Woolworths Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • BrightSpring Health Services:企業の戦略・SWOT・財務分析
    BrightSpring Health Services - Strategy, SWOT and Corporate Finance Report Summary BrightSpring Health Services - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Votorantim SA:企業の戦略的SWOT分析
    Votorantim SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • UBS Group AG:企業のM&A・事業提携・投資動向
    UBS Group AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UBS Group AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Fulcrum Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Fulcrum Therapeutics Inc (Fulcrum Therapeutics) is a biotechnology company which focuses on the discovery and development of small molecule therapies to unlock the gene control. Its pipeline portfolio includes Fragile X syndrome (FXS) and facioscapulohumeral muscular dystrophy (FSHD). Fulcru …
  • METRO Retail Stores Group Inc (MRSGI):企業の財務・戦略的SWOT分析
    METRO Retail Stores Group Inc (MRSGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • AVX Corp (AVX):企業の財務・戦略的SWOT分析
    AVX Corp (AVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Central Asia Metals PLC:企業の戦略・SWOT・財務情報
    Central Asia Metals PLC - Strategy, SWOT and Corporate Finance Report Summary Central Asia Metals PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Neiman Marcus Group LTD LLC:企業の戦略・SWOT・財務分析
    Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report Summary Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆